Shiu Kin Yee, McLaughlin Laura, Rebollo-Mesa Irene, Zhao Jingyue, Burton Hannah, Douthwaite Harriet, Wilkinson Hannah, Semik Vikki, Dodd Philippa C, Brookes Paul, Lechler Robert I, Hernandez-Fuentes Maria P, Kemper Claudia, Dorling Anthony
MRC Centre for Transplantation, King's College London, Guy's Hospital, London, UK.
Imperial College London and Imperial College NHS Trust, Hammersmith Hospital, London, UK.
Kidney Int. 2017 Feb;91(2):477-492. doi: 10.1016/j.kint.2016.10.009. Epub 2016 Dec 15.
Chronic antibody-mediated rejection, a common cause of renal transplant failure, has a variable clinical phenotype. Understanding why some with chronic antibody-mediated rejection progress slowly may help develop more effective therapies. B lymphocytes act as antigen-presenting cells for in vitro indirect antidonor interferon-γ production in chronic antibody-mediated rejection, but many patients retain the ability to regulate these responses. Here we test whether particular patterns of T and B cell antidonor response associate with the variability of graft dysfunction in chronic antibody-mediated rejection. Our results confirm that dynamic changes in indirect antidonor CD4 T-cell responses correlate with changes in estimated glomerular filtration rates, independent of other factors. Graft dysfunction progressed rapidly in patients who developed unregulated B-cell-driven interferon-γ production. However, conversion to a regulated or nonreactive pattern, which could be achieved by optimization of immunosuppression, associated with stabilization of graft function. Functional regulation by B cells appeared to activate an interleukin-10 autocrine pathway in CD4 T cells that, in turn, impacted on antigen-specific responses. Thus, our data significantly enhance the understanding of graft dysfunction associated with chronic antibody-mediated rejection and provide the foundation for strategies to prolong renal allograft survival, based on regulation of interferon-γ production.
慢性抗体介导的排斥反应是肾移植失败的常见原因,具有多种临床表型。了解为何一些慢性抗体介导的排斥反应患者进展缓慢,可能有助于开发更有效的治疗方法。在慢性抗体介导的排斥反应中,B淋巴细胞作为抗原呈递细胞,参与体外间接抗供体干扰素-γ的产生,但许多患者仍具备调节这些反应的能力。在此,我们测试T细胞和B细胞抗供体反应的特定模式是否与慢性抗体介导的排斥反应中移植肾功能障碍的变异性相关。我们的结果证实,间接抗供体CD4 T细胞反应的动态变化与估计肾小球滤过率的变化相关,且不受其他因素影响。在那些出现不受调控的B细胞驱动的干扰素-γ产生的患者中,移植肾功能障碍进展迅速。然而,通过优化免疫抑制可实现向受调控或无反应模式的转变,这与移植肾功能的稳定相关。B细胞的功能调节似乎激活了CD4 T细胞中的白细胞介素-10自分泌途径,进而影响抗原特异性反应。因此,我们的数据显著增进了对与慢性抗体介导的排斥反应相关的移植肾功能障碍的理解,并为基于干扰素-γ产生调节来延长肾移植存活时间的策略奠定了基础。